N.J. Admin. Code § 13:39-13.4

Current through Register Vol. 56, No. 24, December 18, 2024

Section 13:39-13.4 - Collaborative practice agreement

(a) A pharmacist who engages in collaborative practice with one or more physicians shall provide the Board, upon request, with a signed copy of a collaborative practice agreement. The collaborative practice agreement shall be consistent with the example contained in N.J.A.C. 13:39-13 Appendix, which is incorporated herein by reference. The written agreement shall:

1. Identify, by name and title, each physician and each pharmacist who is permitted to participate in a patient's collaborative drug therapy management, including all covering physicians and/or pharmacists. Each covering physician shall meet the requirements of N.J.A.C. 13:35-6.27(b) and each covering pharmacist shall meet the requirements of N.J.A.C. 13:39-13.3. The agreement shall establish the means by which the physician and/or pharmacist will be notified about covering practitioners for collaborative practice purposes;

2. Specify the functions and responsibilities, including the scope of practice and authority, to be exercised by the pharmacist;

3. Indicate any restrictions placed on the use of certain types or classes of drugs or drug therapies;

4. Indicate any diagnosis or types of diseases that are specifically included or excluded;

5. Include copies of all protocols to be used in the collaborative practice;

6. Contain an effective date for the agreement; and

7. Be signed and dated by the physician(s) and pharmacist(s).

(b) Any changes, additions, or deletions to the collaborative practice agreement shall be submitted to the Board upon request.

(c) The pharmacist shall cooperate with the method established by the physician for monitoring compliance with the agreement and clinical outcomes of the patients.

(d) The collaborative practice agreement may be terminated at any time by either the physician or the pharmacist by written documentation. Upon termination of a collaborative practice agreement, the physician and the pharmacist shall provide notice of the termination to each individual patient who is undergoing collaborative drug therapy management. Upon termination of the agreement, the patient's informed consent for collaborative drug therapy management under the agreement shall be voided.

(e) All records relating to a collaborative practice agreement shall be maintained in either hard copy or electronic form for a period of not less than seven years from the date of termination of the agreement and shall be supplied to the Board upon request. All records shall be made available to persons authorized to inspect them under State and Federal statutes and regulations. The oldest six years of information shall be maintained in such a manner, so as to be retrievable and readable within two weeks. The most recent one year of information shall be retrievable and readable within one business day. Records not currently in use need not be stored in the pharmacy, but the storage facilities shall be secure. Patient records shall be kept confidential.

N.J. Admin. Code § 13:39-13.4